For research use only. We do not sell to patients.
| Name | IRAK-1-4 Inhibitor I |
|---|---|
| Iupac Chemical Name | N-[1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]-3-nitrobenzamide |
| Synonyms | Benzamide,N-[1-[2-(4-morpholinyl)ethyl]-1H-benzimidazol-2-yl]-3-nitro; IRAK-1/4 Inhibitor |
| Molecular Formula | C20H21N5O4 |
| Molecular Weight | 395.41 |
| Smile | O=C(NC3=NC2=CC=CC=C2N3CCN4CCOCC4)C1=CC=CC([N+]([O-])=O)=C1 |
| InChiKey | QTCFYQHZJIIHBS-UHFFFAOYSA-N |
| InChi | InChI=1S/C20H21N5O4/c26-19(15-4-3-5-16(14-15)25(27)28)22-20-21-17-6-1-2-7-18(17)24(20)9-8-23-10-12-29-13-11-23/h1-7,14H,8-13H2,(H,21,22,26) |
| CAS Number | 509093-47-4 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Solid powder |
|---|---|
| Purity | 98% |
| Storage | -20 ºC for 3 years |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |